APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunity Nutraceutical Ingredient

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immunity Nutraceutical Ingredient Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchImmunity Nutraceutical Ingredient Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunity Nutraceutical Ingredient Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Immunity Nutraceutical Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunity Nutraceutical Ingredient Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunity Nutraceutical Ingredient Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Immunity Nutraceutical Ingredient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immunity Nutraceutical Ingredient market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immunity Nutraceutical Ingredient market include Tate & Lyle PLC (U.K), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunity Nutraceutical Ingredient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunity Nutraceutical Ingredient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunity Nutraceutical Ingredient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunity Nutraceutical Ingredient market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunity Nutraceutical Ingredient Segment by Company

Tate & Lyle PLC (U.K)

Koninklijke DSM N.V. (Netherlands)

Ingredion Incorporated (U.S)

Arla Foods (Denmark)

Ajinomoto Co., Inc. (Japan)

Immunity Nutraceutical Ingredient Segment by Type

Carotenoids

Minerals

Omega-3 fatty acids

Fibers & specialty carbohydrates

Phytochemical and plant extracts

Others

Immunity Nutraceutical Ingredient Segment by Application

Dietary supplements

Functional beverages

Functional food

Personal care

Animal nutrition

Immunity Nutraceutical Ingredient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immunity Nutraceutical Ingredient status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immunity Nutraceutical Ingredient market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immunity Nutraceutical Ingredient significant trends, drivers, influence factors in global and regions.

6. To analyze Immunity Nutraceutical Ingredient competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Nutraceutical Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunity Nutraceutical Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Nutraceutical Ingredient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunity Nutraceutical Ingredient market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunity Nutraceutical Ingredient industry.

Chapter 3: Detailed analysis of Immunity Nutraceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immunity Nutraceutical Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immunity Nutraceutical Ingredient in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immunity Nutraceutical Ingredient Industry Trends Table 2. Immunity Nutraceutical Ingredient Industry Drivers Table 3. Immunity Nutraceutical Ingredient Industry Opportunities and Challenges Table 4. Immunity Nutraceutical Ingredient Industry Restraints Table 5. Global Immunity Nutraceutical Ingredient Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immunity Nutraceutical Ingredient Revenue Share by Company (2021-2026) Table 7. Global Immunity Nutraceutical Ingredient Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Immunity Nutraceutical Ingredient Sales Volume Share by Company (2021-2026) Table 9. Global Immunity Nutraceutical Ingredient Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Immunity Nutraceutical Ingredient Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immunity Nutraceutical Ingredient Key Company Manufacturing Base & Headquarters Table 12. Global Immunity Nutraceutical Ingredient Company, Product Type & Application Table 13. Global Immunity Nutraceutical Ingredient Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunity Nutraceutical Ingredient by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Carotenoids Table 18. Significant Companies of Minerals Table 19. Significant Companies of Omega-3 fatty acids Table 20. Significant Companies of Fibers & specialty carbohydrates Table 21. Significant Companies of Phytochemical and plant extracts Table 22. Significant Companies of Others Table 23. Global Immunity Nutraceutical Ingredient Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Immunity Nutraceutical Ingredient Sales Volume by Type (2021-2026) & (Tons) Table 25. Global Immunity Nutraceutical Ingredient Sales Volume by Type (2027-2032) & (Tons) Table 26. Global Immunity Nutraceutical Ingredient Sales Volume Share by Type (2021-2026) Table 27. Global Immunity Nutraceutical Ingredient Sales Volume Share by Type (2027-2032) Table 28. Global Immunity Nutraceutical Ingredient Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Immunity Nutraceutical Ingredient Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Immunity Nutraceutical Ingredient Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Immunity Nutraceutical Ingredient Sales Value Share by Type (2021-2026) Table 32. Global Immunity Nutraceutical Ingredient Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Dietary supplements Table 34. Significant Companies of Functional beverages Table 35. Significant Companies of Functional food Table 36. Significant Companies of Personal care Table 37. Significant Companies of Animal nutrition Table 38. Global Immunity Nutraceutical Ingredient Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Immunity Nutraceutical Ingredient Sales Volume by Application (2021-2026) & (Tons) Table 40. Global Immunity Nutraceutical Ingredient Sales Volume by Application (2027-2032) & (Tons) Table 41. Global Immunity Nutraceutical Ingredient Sales Volume Share by Application (2021-2026) Table 42. Global Immunity Nutraceutical Ingredient Sales Volume Share by Application (2027-2032) Table 43. Global Immunity Nutraceutical Ingredient Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Immunity Nutraceutical Ingredient Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Immunity Nutraceutical Ingredient Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Immunity Nutraceutical Ingredient Sales Value Share by Application (2021-2026) Table 47. Global Immunity Nutraceutical Ingredient Sales Value Share by Application (2027-2032) Table 48. Global Immunity Nutraceutical Ingredient Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 49. Global Immunity Nutraceutical Ingredient Sales by Region (2021-2026) & (Tons) Table 50. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2021-2026) Table 51. Global Immunity Nutraceutical Ingredient Sales by Region (2027-2032) & (Tons) Table 52. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2027-2032) Table 53. Global Immunity Nutraceutical Ingredient Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Immunity Nutraceutical Ingredient Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Immunity Nutraceutical Ingredient Sales Value Share by Region (2021-2026) Table 56. Global Immunity Nutraceutical Ingredient Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Immunity Nutraceutical Ingredient Sales Value Share by Region (2027-2032) Table 58. Global Immunity Nutraceutical Ingredient Market Average Price (US$/Kg) by Region (2021-2026) Table 59. Global Immunity Nutraceutical Ingredient Market Average Price (US$/Kg) by Region (2027-2032) Table 60. Global Immunity Nutraceutical Ingredient Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 61. Global Immunity Nutraceutical Ingredient Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Immunity Nutraceutical Ingredient Sales by Country (2021-2026) & (Tons) Table 63. Global Immunity Nutraceutical Ingredient Sales Market Share by Country (2021-2026) Table 64. Global Immunity Nutraceutical Ingredient Sales by Country (2027-2032) & (Tons) Table 65. Global Immunity Nutraceutical Ingredient Sales Market Share by Country (2027-2032) Table 66. Global Immunity Nutraceutical Ingredient Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Immunity Nutraceutical Ingredient Sales Value Market Share by Country (2021-2026) Table 68. Global Immunity Nutraceutical Ingredient Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Immunity Nutraceutical Ingredient Sales Value Market Share by Country (2027-2032) Table 70. Tate & Lyle PLC (U.K) Company Information Table 71. Tate & Lyle PLC (U.K) Business Overview Table 72. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio Table 74. Tate & Lyle PLC (U.K) Recent Development Table 75. Koninklijke DSM N.V. (Netherlands) Company Information Table 76. Koninklijke DSM N.V. (Netherlands) Business Overview Table 77. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio Table 79. Koninklijke DSM N.V. (Netherlands) Recent Development Table 80. Ingredion Incorporated (U.S) Company Information Table 81. Ingredion Incorporated (U.S) Business Overview Table 82. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio Table 84. Ingredion Incorporated (U.S) Recent Development Table 85. Arla Foods (Denmark) Company Information Table 86. Arla Foods (Denmark) Business Overview Table 87. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio Table 89. Arla Foods (Denmark) Recent Development Table 90. Ajinomoto Co., Inc. (Japan) Company Information Table 91. Ajinomoto Co., Inc. (Japan) Business Overview Table 92. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio Table 94. Ajinomoto Co., Inc. (Japan) Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Immunity Nutraceutical Ingredient Distributors List Table 98. Immunity Nutraceutical Ingredient Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Immunity Nutraceutical Ingredient Product Image Figure 2. Global Immunity Nutraceutical Ingredient Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunity Nutraceutical Ingredient Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immunity Nutraceutical Ingredient Sales (2021-2032) & (Tons) Figure 5. Global Immunity Nutraceutical Ingredient Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Immunity Nutraceutical Ingredient Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Carotenoids Image Figure 10. Minerals Image Figure 11. Omega-3 fatty acids Image Figure 12. Fibers & specialty carbohydrates Image Figure 13. Phytochemical and plant extracts Image Figure 14. Others Image Figure 15. Global Immunity Nutraceutical Ingredient Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Immunity Nutraceutical Ingredient Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Immunity Nutraceutical Ingredient Sales Volume Share by Type (2021-2032) Figure 18. Global Immunity Nutraceutical Ingredient Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Immunity Nutraceutical Ingredient Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Immunity Nutraceutical Ingredient Sales Value Share by Type (2021-2032) Figure 21. Dietary supplements Image Figure 22. Functional beverages Image Figure 23. Functional food Image Figure 24. Personal care Image Figure 25. Animal nutrition Image Figure 26. Global Immunity Nutraceutical Ingredient Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 27. Global Immunity Nutraceutical Ingredient Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Immunity Nutraceutical Ingredient Sales Volume Share by Application (2021-2032) Figure 29. Global Immunity Nutraceutical Ingredient Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Immunity Nutraceutical Ingredient Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Immunity Nutraceutical Ingredient Sales Value Share by Application (2021-2032) Figure 32. Global Immunity Nutraceutical Ingredient Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 33. Global Immunity Nutraceutical Ingredient Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Immunity Nutraceutical Ingredient Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Immunity Nutraceutical Ingredient Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Immunity Nutraceutical Ingredient Sales Value (2021-2032) & (US$ Million) Figure 37. North America Immunity Nutraceutical Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Immunity Nutraceutical Ingredient Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Immunity Nutraceutical Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Immunity Nutraceutical Ingredient Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Immunity Nutraceutical Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Immunity Nutraceutical Ingredient Sales Value (2021-2032) & (US$ Million) Figure 43. South America Immunity Nutraceutical Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Immunity Nutraceutical Ingredient Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Immunity Nutraceutical Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Immunity Nutraceutical Ingredient Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Immunity Nutraceutical Ingredient Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Carotenoids
  • Minerals
  • Omega-3 fatty acids
  • Fibers & specialty carbohydrates
  • Phytochemical and plant extracts
  • Others
Applications
  • Dietary supplements
  • Functional beverages
  • Functional food
  • Personal care
  • Animal nutrition
Companies covered
  • Tate & Lyle PLC (U.K)
  • Koninklijke DSM N.V. (Netherlands)
  • Ingredion Incorporated (U.S)
  • Arla Foods (Denmark)
  • Ajinomoto Co., Inc. (Japan)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunity Nutraceutical Ingredient Sales Value (2021-2032)
  4. 1.2.2 Global Immunity Nutraceutical Ingredient Sales Volume (2021-2032)
  5. 1.2.3 Global Immunity Nutraceutical Ingredient Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immunity Nutraceutical Ingredient Market Dynamics
  1. 2.1 Immunity Nutraceutical Ingredient Industry Trends
  2. 2.2 Immunity Nutraceutical Ingredient Industry Drivers
  3. 2.3 Immunity Nutraceutical Ingredient Industry Opportunities and Challenges
  4. 2.4 Immunity Nutraceutical Ingredient Industry Restraints
3 Immunity Nutraceutical Ingredient Market by Company
  1. 3.1 Global Immunity Nutraceutical Ingredient Company Revenue Ranking in 2025
  2. 3.2 Global Immunity Nutraceutical Ingredient Revenue by Company (2021-2026)
  3. 3.3 Global Immunity Nutraceutical Ingredient Sales Volume by Company (2021-2026)
  4. 3.4 Global Immunity Nutraceutical Ingredient Average Price by Company (2021-2026)
  5. 3.5 Global Immunity Nutraceutical Ingredient Company Ranking (2024-2026)
  6. 3.6 Global Immunity Nutraceutical Ingredient Company Manufacturing Base and Headquarters
  7. 3.7 Global Immunity Nutraceutical Ingredient Company Product Type and Application
  8. 3.8 Global Immunity Nutraceutical Ingredient Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immunity Nutraceutical Ingredient Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immunity Nutraceutical Ingredient Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immunity Nutraceutical Ingredient Market by Type
  1. 4.1 Immunity Nutraceutical Ingredient Type Introduction
  2. 4.1.1 Carotenoids
  3. 4.1.2 Minerals
  4. 4.1.3 Omega-3 fatty acids
  5. 4.1.4 Fibers & specialty carbohydrates
  6. 4.1.5 Phytochemical and plant extracts
  7. 4.1.6 Others
  8. 4.2 Global Immunity Nutraceutical Ingredient Sales Volume by Type
  9. 4.2.1 Global Immunity Nutraceutical Ingredient Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Immunity Nutraceutical Ingredient Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Immunity Nutraceutical Ingredient Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Immunity Nutraceutical Ingredient Sales Value by Type
  13. 4.3.1 Global Immunity Nutraceutical Ingredient Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Immunity Nutraceutical Ingredient Sales Value by Type (2021-2032)
  15. 4.3.3 Global Immunity Nutraceutical Ingredient Sales Value Share by Type (2021-2032)
5 Immunity Nutraceutical Ingredient Market by Application
  1. 5.1 Immunity Nutraceutical Ingredient Application Introduction
  2. 5.1.1 Dietary supplements
  3. 5.1.2 Functional beverages
  4. 5.1.3 Functional food
  5. 5.1.4 Personal care
  6. 5.1.5 Animal nutrition
  7. 5.2 Global Immunity Nutraceutical Ingredient Sales Volume by Application
  8. 5.2.1 Global Immunity Nutraceutical Ingredient Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Immunity Nutraceutical Ingredient Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Immunity Nutraceutical Ingredient Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Immunity Nutraceutical Ingredient Sales Value by Application
  12. 5.3.1 Global Immunity Nutraceutical Ingredient Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Immunity Nutraceutical Ingredient Sales Value by Application (2021-2032)
  14. 5.3.3 Global Immunity Nutraceutical Ingredient Sales Value Share by Application (2021-2032)
6 Immunity Nutraceutical Ingredient Regional Sales and Value Analysis
  1. 6.1 Global Immunity Nutraceutical Ingredient Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunity Nutraceutical Ingredient Sales by Region (2021-2032)
  3. 6.2.1 Global Immunity Nutraceutical Ingredient Sales by Region: 2021-2026
  4. 6.2.2 Global Immunity Nutraceutical Ingredient Sales by Region (2027-2032)
  5. 6.3 Global Immunity Nutraceutical Ingredient Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immunity Nutraceutical Ingredient Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immunity Nutraceutical Ingredient Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immunity Nutraceutical Ingredient Sales Value by Region (2027-2032)
  9. 6.5 Global Immunity Nutraceutical Ingredient Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immunity Nutraceutical Ingredient Sales Value (2021-2032)
  12. 6.6.2 North America Immunity Nutraceutical Ingredient Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immunity Nutraceutical Ingredient Sales Value (2021-2032)
  15. 6.7.2 Europe Immunity Nutraceutical Ingredient Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immunity Nutraceutical Ingredient Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immunity Nutraceutical Ingredient Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immunity Nutraceutical Ingredient Sales Value (2021-2032)
  21. 6.9.2 South America Immunity Nutraceutical Ingredient Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immunity Nutraceutical Ingredient Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immunity Nutraceutical Ingredient Sales Value Share by Country, 2025 VS 2032
7 Immunity Nutraceutical Ingredient Country-level Sales and Value Analysis
  1. 7.1 Global Immunity Nutraceutical Ingredient Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immunity Nutraceutical Ingredient Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
  4. 7.3.1 Global Immunity Nutraceutical Ingredient Sales by Country (2021-2026)
  5. 7.3.2 Global Immunity Nutraceutical Ingredient Sales by Country (2027-2032)
  6. 7.4 Global Immunity Nutraceutical Ingredient Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immunity Nutraceutical Ingredient Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immunity Nutraceutical Ingredient Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immunity Nutraceutical Ingredient Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immunity Nutraceutical Ingredient Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immunity Nutraceutical Ingredient Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tate & Lyle PLC (U.K)
  2. 8.1.1 Tate & Lyle PLC (U.K) Company Information
  3. 8.1.2 Tate & Lyle PLC (U.K) Business Overview
  4. 8.1.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio
  6. 8.1.5 Tate & Lyle PLC (U.K) Recent Developments
  7. 8.2 Koninklijke DSM N.V. (Netherlands)
  8. 8.2.1 Koninklijke DSM N.V. (Netherlands) Company Information
  9. 8.2.2 Koninklijke DSM N.V. (Netherlands) Business Overview
  10. 8.2.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio
  12. 8.2.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
  13. 8.3 Ingredion Incorporated (U.S)
  14. 8.3.1 Ingredion Incorporated (U.S) Company Information
  15. 8.3.2 Ingredion Incorporated (U.S) Business Overview
  16. 8.3.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio
  18. 8.3.5 Ingredion Incorporated (U.S) Recent Developments
  19. 8.4 Arla Foods (Denmark)
  20. 8.4.1 Arla Foods (Denmark) Company Information
  21. 8.4.2 Arla Foods (Denmark) Business Overview
  22. 8.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio
  24. 8.4.5 Arla Foods (Denmark) Recent Developments
  25. 8.5 Ajinomoto Co., Inc. (Japan)
  26. 8.5.1 Ajinomoto Co., Inc. (Japan) Company Information
  27. 8.5.2 Ajinomoto Co., Inc. (Japan) Business Overview
  28. 8.5.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio
  30. 8.5.5 Ajinomoto Co., Inc. (Japan) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunity Nutraceutical Ingredient Value Chain Analysis
  2. 9.1.1 Immunity Nutraceutical Ingredient Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunity Nutraceutical Ingredient Sales Mode & Process
  6. 9.2 Immunity Nutraceutical Ingredient Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunity Nutraceutical Ingredient Distributors
  9. 9.2.3 Immunity Nutraceutical Ingredient Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst